Profile
Sector:
HealthcareIndustry:
BiotechnologyCountry:
United StatesIPO:
01 May 2007Website:
http://www.oramed.comNext earnings report:
09 May 2025Last dividends:
N/ANext dividends:
N/APrice
after hours | Sat, 16 Nov 2024 00:31:56 GMTDividend
Analysts recommendations
Institutional Ownership
What type of business is Oramed Pharmaceuticals?
Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules for delivery of polypeptides. The company's product portfolio includes ORMD-0801, an oral insulin capsule, which is in phase III clinical trial for the treatment of individuals with diabetes, as well as in phase II clinical trial for the treatment of non-alcoholic steatohepatitis; and ORA-D-013-1 and ORA-D-013-2, which have completed phase II clinical trial for the treatment of type 2 diabetes. It has license agreements with Oravax Medical Inc. to commercialize oral vaccines for COVID-19 and other novel coronaviruses. Oramed Pharmaceuticals Inc. was incorporated in 2002 and is headquartered in New York.
What sector is Oramed Pharmaceuticals in?
Oramed Pharmaceuticals is in the Healthcare sector
What industry is Oramed Pharmaceuticals in?
Oramed Pharmaceuticals is in the Biotechnology industry
What country is Oramed Pharmaceuticals from?
Oramed Pharmaceuticals is headquartered in United States
When did Oramed Pharmaceuticals go public?
Oramed Pharmaceuticals initial public offering (IPO) was on 01 May 2007
What is Oramed Pharmaceuticals website?
https://www.oramed.com
Is Oramed Pharmaceuticals in the S&P 500?
No, Oramed Pharmaceuticals is not included in the S&P 500 index
Is Oramed Pharmaceuticals in the NASDAQ 100?
No, Oramed Pharmaceuticals is not included in the NASDAQ 100 index
Is Oramed Pharmaceuticals in the Dow Jones?
No, Oramed Pharmaceuticals is not included in the Dow Jones index
When was Oramed Pharmaceuticals the previous earnings report?
No data
When does Oramed Pharmaceuticals earnings report?
The next expected earnings date for Oramed Pharmaceuticals is 09 May 2025